187 related articles for article (PubMed ID: 33178574)
1. A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers.
Su X; He HC; Ye ZL; Zhou DL; Liu Q; Yang XH; Long YK; Tang T; Ma JJ; Xu BH; Chen WC; He CY; Yang AK
Front Oncol; 2020; 10():535893. PubMed ID: 33178574
[TBL] [Abstract][Full Text] [Related]
2. Retrospective assessment of neoadjuvant camrelizumab combined with induction chemotherapy: efficacy in laryngeal preservation for advanced hypopharyngeal and laryngeal squamous cell carcinoma.
Peng J; Luo G; Yu Y; Ning K; Liu X
Cancer Immunol Immunother; 2024 Feb; 73(3):54. PubMed ID: 38358522
[TBL] [Abstract][Full Text] [Related]
3. Functional Larynx Preservation in Patients With Locally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx Treated With Induction Chemotherapy vs. Concurrent Chemoradiation Alone.
Nehlsen AD; Lehrer EJ; Dickstein DR; Posner MR; Misiukiewicz K; Liu J; Gupta V; Bakst RL; Sharma S
Cureus; 2021 Jul; 13(7):e16310. PubMed ID: 34405069
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
5. PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study.
Fang Q; Xu P; Cao F; Wu D; Liu X
Cancer Immunol Immunother; 2023 Dec; 72(12):4161-4168. PubMed ID: 37804437
[TBL] [Abstract][Full Text] [Related]
6. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
7. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
8. Laryngeal Preservation Strategies in Locally Advanced Laryngeal and Hypopharyngeal Cancers.
Argiris A; Lefebvre JL
Front Oncol; 2019; 9():419. PubMed ID: 31214491
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy-based organ-preservation protocol improve the function preservation compared with immediate total laryngectomy for locally advanced hypopharyngeal cancer-Results of a matched-pair analysis.
Yang Y; Feng L; Zhong Q; Zhang Y; Huang Z; Zhang S; Li S; Gao J; Hou L; Ma H; He S; Shi Q; Lian M; Zhao Y; Shen X; Chen J; Wang L; Li H; Chen S; Xu J; Wang R; Fang J
Cancer Med; 2023 Aug; 12(16):17078-17086. PubMed ID: 37466348
[TBL] [Abstract][Full Text] [Related]
11. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
12. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
Varghese BT; Sebastian P; Mathew A
Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
[TBL] [Abstract][Full Text] [Related]
14. Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma.
Luo X; Huang X; Liu S; Wang X; Luo J; Xiao J; Wang K; Qu Y; Chen X; Zhang Y; Wang J; Zhang J; Xu G; Gao L; Wu R; Yi J
JAMA Netw Open; 2022 Feb; 5(2):e220165. PubMed ID: 35191967
[TBL] [Abstract][Full Text] [Related]
15. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
[TBL] [Abstract][Full Text] [Related]
16. Matched-Pair Analysis of Survival in the Patients with Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma Treated with Induction Chemotherapy Plus Chemo-Radiation or Total Laryngectomy.
García-Cabo P; López F; Sánchez-Canteli M; Fernández-Vañes L; Álvarez-Marcos C; Llorente JL; Rúa MÁ; Blay P; Rodrigo JP
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917434
[TBL] [Abstract][Full Text] [Related]
17. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
[TBL] [Abstract][Full Text] [Related]
18. Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers.
Nair SV; Mair M; Sawarkar N; Chakrabarti S; Qayyumi B; Nair D; Chaturvedi P; Gupta T; Agrawal JP
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2311-2316. PubMed ID: 29959566
[TBL] [Abstract][Full Text] [Related]
19. Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population.
Marruecos-Querol J; Rubió-Casadevall J; Lozano A; Buxó M; Puigdemont M; Linares I; Planas I; Vayreda J; Cirauqui B; Taberna M; Quiroga V; Tobed M; Borés A; Recalde S; Saigi M; Felip E; Eraso A; Mesía R
Clin Transl Oncol; 2023 Aug; 25(8):2384-2392. PubMed ID: 36943650
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
Bonner J; Giralt J; Harari P; Spencer S; Schulten J; Hossain A; Chang SC; Chin S; Baselga J
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):842-9. PubMed ID: 27389475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
